Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126869771 | 12686977 | 1 | I | 20160812 | 20160826 | 20160826 | EXP | JP-ALVOGEN-2016-ALVOGEN-027827 | ALVOGEN | TAKAZAWA, T. A CASE OF ACUTE ONSET POSTOPERATIVE GAS GANGRENE CAUSED BY CLOSTRIDIUM PERFRINGENS. BMC RESEARCH NOTES, 2016, VOL 9(1), PGS 385. | 65.00 | YR | F | Y | 0.00000 | 20160826 | OT | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126869771 | 12686977 | 1 | PS | CLINDAMYCIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 62800 | 900 | MG | ||||||||||
| 126869771 | 12686977 | 2 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 3 | SS | IMIPENEM AND CILASTATIN | CILASTATIN SODIUMIMIPENEM | 1 | 0 | 500 | MG | ||||||||||
| 126869771 | 12686977 | 4 | SS | MEROPENEM. | MEROPENEM | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 5 | SS | VANCOMYCIN | VANCOMYCIN | 1 | 0 | 1000 | MG | ||||||||||
| 126869771 | 12686977 | 6 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 7 | SS | CEFTAZIDIME. | CEFTAZIDIME | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 8 | SS | FOSFOMYCIN | FOSFOMYCIN | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 9 | SS | ISEPAMICIN | ISEPAMICIN | 1 | 0 | 200 | MG | ||||||||||
| 126869771 | 12686977 | 10 | C | POLYMYXIN B. | POLYMYXIN B | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 11 | C | RINGER | 2 | 0 | SOLUTION FOR INFUSION | ||||||||||||
| 126869771 | 12686977 | 12 | C | ALBUMIN | ALBUMIN HUMAN | 1 | 0 | ||||||||||||
| 126869771 | 12686977 | 13 | C | IMMUNOGLOBULINS | HUMAN IMMUNOGLOBULIN G | 1 | U | 0 | |||||||||||
| 126869771 | 12686977 | 14 | C | LYPRESSIN | LYPRESSIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126869771 | 12686977 | 1 | Antibiotic therapy |
| 126869771 | 12686977 | 2 | Antibiotic therapy |
| 126869771 | 12686977 | 3 | Antibiotic therapy |
| 126869771 | 12686977 | 4 | Antibiotic therapy |
| 126869771 | 12686977 | 5 | Antibiotic therapy |
| 126869771 | 12686977 | 6 | Product used for unknown indication |
| 126869771 | 12686977 | 7 | Product used for unknown indication |
| 126869771 | 12686977 | 8 | Antibiotic therapy |
| 126869771 | 12686977 | 9 | Pyrexia |
| 126869771 | 12686977 | 10 | Product used for unknown indication |
| 126869771 | 12686977 | 11 | Product used for unknown indication |
| 126869771 | 12686977 | 12 | Product used for unknown indication |
| 126869771 | 12686977 | 13 | Product used for unknown indication |
| 126869771 | 12686977 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126869771 | 12686977 | DE |
| 126869771 | 12686977 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126869771 | 12686977 | Drug resistance | |
| 126869771 | 12686977 | Multiple organ dysfunction syndrome | |
| 126869771 | 12686977 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |